Leukemia & lymphoma/Leukemia and lymphoma · 2005 · 11 citations · 21 references
MedicineHematologyOncologyHematologic OncologyImmunotherapyStem Cell TransplantationCancer ImmunotherapyChemotherapy In Hematologic MalignanciesHematologic Malignancy TherapyHigh-dose ChemotherapyLymphoid NeoplasmsLymphoid TumorsLymphoma Treatment ResponsePrimary Mediastinal Large B-cell LymphomaPrimary Mediastinal LymphomaPrimary Refractory LymphomaRituximab-based Therapy
Patients with primary large B-cell lymphomas of the mediastinum (PMBL) who suffer early relapse have a low likelihood of achieving a prolonged second remission with conventional salvage therapy. Here we describe the case of a 33-year-old woman with PMBL refractory to 6 lines of therapy before undergoing salvage therapy with rituximab, ifosfamide and etoposide followed by high-dose therapy, autologous transplantation, and sequential non-myeloablative allogeneic transplantation, who remains in ongoing complete remission for more than 39 months and is apparently cured. The specific roles of the components of the successful salvage therapy are discussed.
21
Andreas Rosenwald, George W. Wright, Karen Leroy et al. · The Journal of Experimental Medicine · 2003 · 1.1K citations · Full text
Medicine, Hematology, Oncology +14
Thierry Philip, Jamés O. Armitage, Gary Spitzer et al. · New England Journal of Medicine · 1987 · 781 citations
Medicine, Hematology, Oncology +17